Neurol. praxi. 2007;8(5):277-282

Autosomálně dominantní spinocerebelární ataxie

MUDr. Alena Zumrová, Ph.D.2, MUDr. Marta Kopečková1, MUDr. Zuzana Mušová1, MUDr. Anna Křepelová, CSc.1, Ludmila Apltová1, MUDr. Kateřina Paděrová2
1 Ústav biologie a lékařské genetiky 2. LF UK a FN, Praha
2 Klinika dětské neurologie 2. LF UK a Centrum pro epilepsie FN Motol, Praha

Pokroky na buněčné a fyziologické úrovni poskytují nové informace o mozečku, jeho funkcích i mechanizmech vedoucích k onemocnění. Kromě toho umožňují aktuální genetické poznatky redefinovat původní oblast spinocerebelárních, olivopontocerebelárních, či dle Hardingové cerebelárních ataxií na úrovni analýzy DNA. V současné době zahrnuje skupina autosomálně dominantních spinocerebelárních ataxií 29 chorob, ve světových DNA laboratořích je rutinní diagnostika zavedena u 10 z nich, v České republice je v současné době k dispozici vyšetření AD SCA 1–3, 6–8, DRPLA, vyšetření SCA10, 12 a 17 by mělo být dostupné v nejbližší době. Existuje však řada dalších chorob a syndromů, které mohou tyto choroby mitigovat. Problémem současné neurologické praxe v této oblasti je vypořádat se s exponenciálně narůstajícími poznatky a skloubit je s možnostmi laboratorní diagnostiky.

Keywords: spinocerebelární ataxie, diferenciální diagnostika, DNA diagnostika

Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zumrová A, Kopečková M, Mušová Z, Křepelová A, Apltová L, Paděrová K. Autosomálně dominantní spinocerebelární ataxie. Neurol. praxi. 2007;8(5):277-282.
Download citation

References

  1. Bauer P, Kraus J, Matoska V, Brouckova M, Zumrova A, Goetz P. Large de novo expansion of CAG repeats in patient with sporadic spinocerebellar ataxia type 7. J Neurol 2004; 251 (8): 1023-1024. Go to original source... Go to PubMed...
  2. Brusco A, Gellera C, Cagnoli C, Saluto A, Castucci A, Michielotto C, Fetoni V, Mariotti C, Migone N, Di Donato S, Taroni F. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 2004; 61: 727-733. Go to original source... Go to PubMed...
  3. Cellini E, Forleo P, Nacmias B, Tedde A, Bagnoli S, Piacentini S, Sorbi S. Spinocerebellar ataxia type 17 repeat in patients with Huntington's disease-like and ataxia. Ann Neurol 2004; 56(1): 163. Go to original source... Go to PubMed...
  4. De Michele G, Coppola G, Cocozza S, Filla A. A pathogenetic classification of hereditary ataxias: is the time ripe? J Neurol. 2004; 251 (8): 913-922. Go to original source... Go to PubMed...
  5. Duenas AM, Goold R, Giunti P. Molecular pathogenesis of spinocerebellar ataxias. Brain. 2006; 129(6): 1357-1370. Go to original source... Go to PubMed...
  6. Fischbeck K. Polyglutamine expansion neurodegenerative disease. Brain Research Bulletin 2001; 56: 161-163. Go to original source... Go to PubMed...
  7. Hagerman RJ, Hagerman PJ. The fragile X premutation: into the phenotypic fold.Curr Opin Genet Dev 2002; 12(3): 278-283. Go to original source... Go to PubMed...
  8. Harding AE. Clinical features and classification of inherited ataxias. In: Harding AE, Deufel T (eds) Advances in Neurology. Raven Press, New York, 1993: 1-14.
  9. Ishikawa K, Owada K, Ishida K, Fujigasaki H, Shun Li M, et al. Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells. Neurology. 2001; 56: 1753-1756. Go to original source... Go to PubMed...
  10. Jacquemont S, Hagerman RJ, Leehey M, Grigsby J, Zhang L, Brunberg JA, Greco C, Des Portes V, Jardini T, Levine R, Berry-Kravis E, Brown WT, Schaeffer S, Kissel J, Tassone F, Hagerman PJ. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates.Am J Hum Genet 2003; 72(4): 869-878. Go to original source... Go to PubMed...
  11. Koeppen AH. The pathogenesis of spinocerebellar ataxia. Cerebellum. 2005; 4(1): 62-73. Go to original source... Go to PubMed...
  12. Koyano S, Uchihara T, Fujigasaki H, Nakamura A, Yagashita S, Iwabuchi K. Neuronal intranuclear inclusions in spinocerebellar ataxia type 2: triple-labeling immunofluorescent study. Neurosci Lett. 1999; 273: 117-120. Go to original source... Go to PubMed...
  13. Margolis RL. The spinocerebellar ataxias: order emerges from chaos. Curr Neurol Neurosci Rep 2002; 2(5): 447-456. Go to original source... Go to PubMed...
  14. Schmahmann DJ, Sherman JC. The cerebellar cognitive affective syndrome.Brain 1998; 121: 561-579. Go to original source... Go to PubMed...
  15. Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3: 291-304. Go to original source... Go to PubMed...
  16. Tsuchiya K, Oda T, Yoshida M, Sasaki H, Haga C, Okino H, Tominaga I, Matsui K, Akiyama H, Hashizume Y. Degeneration of the inferior olive in spinocerebellar ataxia 6 may depend on disease duration: report of two autopsy cases and statistical analysis of autopsy cases reported to date. Neuropathology. 2005; 25(2): 125-135. Go to original source... Go to PubMed...
  17. Wu YR, Lee-Chen GJ, Lang AE, Chen CM, Lin HY, Chen ST. Dystonia as a presenting sign of spinocerebellar ataxia type 1. Mov Disord 2004; 19(5): 586-587. Go to original source... Go to PubMed...
  18. Zortea M, Armani M, Pastorello E, Nunez GF, Lombardi S, Tonello S, Rigoni MT, Zuliani L, Mostacciuolo ML, Gellera C, Di Donato S, Trevisan CP. Prevalence of inherited ataxias in the province of Padua, Italy. Neuroepidemiology 2004; 23: 275-280. Go to original source... Go to PubMed...
  19. Zumrova A, Mazanec R, Vyhnalek M, Krepelova A, Musova Z, Krilova S, Appltova L, Havlovicova M. Concomitancy of mutation in FRDA gene and FMR1 premutation in 58 year-old woman. NeuroEndocrinol Lett 2005; 26(1): 71-74. Go to PubMed...
  20. Zumrova A. Problems and possibilities in the differential diagnosis of Syndrome Spinocerebellar Ataxia. NeuroEndocrinol Lett. 2005; 26(2): 98-108. Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.